menu
    • menu

    Company profile for Beijing Sungen Biomedical Technology

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Beijing Sungen Biomedical Technology Co., Ltd. is dedicated to developing first-in-class (FIC) antibody drugs, addressing unmet clinical needs. With a mission to innovate for human health, Sungen has built international-standard technology platforms and original biological macromolecular R&D pipelines with strong market potential. The company focuses on creating innovative therapies for cardiovascular and cerebrovascular disea...
    Beijing Sungen Biomedical Technology Co., Ltd. is dedicated to developing first-in-class (FIC) antibody drugs, addressing unmet clinical needs. With a mission to innovate for human health, Sungen has built international-standard technology platforms and original biological macromolecular R&D pipelines with strong market potential. The company focuses on creating innovative therapies for cardiovascular and cerebrovascular diseases, tumors, and neurodegenerative conditions, striving to become a global leader in antibody research and development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Beijing Sungen Biomedical TechnologyChina Flag
    Country
    Country
    China
    Address
    Address
    No.55 Qingfeng West Road, Daxing District, Beijing
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sungenbiomed.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sungen Bio's SGC001 monoclonal antibody gets FDA fast track Approval
    Sungen Bio's SGC001 monoclonal antibody gets FDA fast track Approval

    24 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sungen-biomedicals-world-first-new-drug-sgc001-monoclonal-antibody-receives-fda-fast-track-approval-302409267.html

    PR NEWSWIRE
    24 Mar 2025
    Share Share
    Sungen Pharma`s generic Ranolazine Receives Approval in US
    Sungen Pharma`s generic Ranolazine Receives Approval in US

    26 Mar 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212781

    FDA
    26 Mar 2020
    Share Share
    Sungen Pharma's generic Amphetamine Aspartate;Amphetamine Sulfate Receives Approval in US
    Sungen Pharma's generic Amphetamine Aspartate;Amphetamine Sulfate Receives Approval in US

    13 Dec 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212037

    FDA
    13 Dec 2019
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search